JPRN-UMIN000016360
Recruiting
未知
Study of Hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal dissemination and appendiceal mucinous neoplasm
Mie university gastrointestinal and pediatric surgery0 sites10 target enrollmentJanuary 28, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mie university gastrointestinal and pediatric surgery
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Patients with peritoneal metastasis of gastric cancer,colon cancer, or appendicecal mucosal neoplasm
- •?Patients with positive peritoneal cytology
- •?Except for cases having distant metastasis such as liver and lung, and cases having non\-healing factor such as unresectable lymph node metastasis except for peritoneal metastasis
Exclusion Criteria
- •?Patients with heart disease(Arrhythmia requiring acute myocardial infarction within 6 months after the onset of ischemic heart disease, a medical treatment)
- •?Patients with a history of cerebrovascular disorder of cerebral infarction, cerebral hemorrhage, etc.
- •?Patients of systolic blood pressure less than 80mmHg or hypotension
- •?During pregnancy, Women suspected of being pregnant and Lactating woman
- •?Patients with dementia
- •?Patients with a history of shock during extracorporeal circulation therapy
- •?Patients taking stop angiotensin converting enzyme inhibitors, is difficult prior to extracorporeal circulation therapy
- •?Patients admitted unsuitable for the clinical study by research investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Hyperthermic intra-peritoneal chemotherapy (HIPEC) in Ovarian cancer recurrence: Randomized trial on Survival Evaluation.EUCTR2012-002872-15-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Active, not recruiting
Not Applicable
Intraperitoneal hyperterm chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal origiAdjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosisthe COLOPEC randomized multicenter trialTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-002794-11-NLAcademic Medical Center176
Completed
Phase 3
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicenter trial.metastases of peritoneumperitoneal carcinomatosis100179901002747610017998NL-OMON47140Academisch Medisch Centrum185
Unknown
Phase 3
Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric CancerAdvanced Gastric AdenocarcinomaNCT02240524Affiliated Cancer Hospital & Institute of Guangzhou Medical University582
Active, not recruiting
Phase 1
Hyperthermic Intraperitoneal Chemotherapy - Gastric Cancer - HIPC in gastric cancerGastric CancerEUCTR2005-004280-31-GBniversity of Dundee62